A Post-Market Retrospective Study on Revision Total Knee Arthroplasty Using Medacta GMK® Revision Prosthesis

NCT02912351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2022-04-01

No results posted yet for this study

Summary

This is a retrospective, single-site observational study, designed to assess the clinical outcomes and collect safety data of GMK Revision knee system used for primary or revision total knee arthroplasty at minimum two years post-treatment.

Conditions

Interventions

OTHER

Patient record review, Radiographs, and questionaires.

KSS-Objective Knee Scores, KSS Subsets, Radiographs and Patient Satisfaction

Sponsors & Collaborators

  • Medacta USA

    lead INDUSTRY

Principal Investigators

  • Mukesh Ahuja, MBBS, MS · Medacta USA, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02912351 on ClinicalTrials.gov